Bio-Thera Solutions,(688177) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

CN Stock MarketDetailed Quotes

688177 Bio-Thera Solutions,

Watchlist

20.44
+0.29+1.44%

Market Closed Mar 28 15:00 CST

8.46BMarket Cap-22.41P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Bio-Thera and DR. Reddy's Execute Exclusive Commercialization Agreement for Bat2206 and Bat2506
ReutersMar 27 11:47 ET
GTJA: Continuous iteration of anti-tumor therapies, domestic new drugs welcome breakthroughs.
GTJA focuses on products with significant differentiation advantages and leading companies in innovative segments.
Zhitong FinanceMar 16 21:18 ET
Bio-Thera Solutions Obtains Acceptance of Marketing Authorization Application for Golimumab Injection
MT NewswiresMar 14 04:46 ET
Further Weakness as Bio-Thera Solutions (SHSE:688177) Drops 4.4% This Week, Taking Five-year Losses to 61%
Simply Wall StMar 10 21:19 ET
Biotech: Biotech 2024 Annual Results Report Announcement
SZSIFeb 25 11:00 ET · Announcements
Biotech 2024 Annual Results Report Announcement
SZSIFeb 25 11:00 ET · Announcements

Comments

Moomoo AI

Mar 15, 2024 06:28

Despite weak revenue forecasts, Bio-Thera Solutions' high P/S ratio shows investor optimism. However, revenue growth could impact share price. With a weak revenue outlook, share price may decline, affecting P/S figures. Investors should be cautious.

Bio-Thera Solutions, Ltd.'s (SHSE:688177) 26% Price Boost Is Out Of Tune With Revenues

Moomoo AI

Jan 27, 2024 09:13

Despite a high P/S ratio, the company's growth rates are limited. Investors may face disappointment if the P/S falls in line with recent growth rates. The high P/S ratio may not be justified given recent performance.

Bio-Thera Solutions, Ltd.'s (SHSE:688177) Price Is Out Of Tune With Revenues

Moomoo AI

Nov 14, 2023 08:22

Bio-Thera Solutions maintains strong finances but loss at EBIT level and fall in revenue indicate future risks. The company's financial developments need monitoring due to these risks.

Is Bio-Thera Solutions (SHSE:688177) Using Debt In A Risky Way?

688177 Bio-Thera Solutions,

Trade Overview

Capital Trend

News

Comments

Market Insights